Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

FDA clears next-gen heart device | Catching up with SCAI's new president | A warning for cath labs | Late-breaking PCI data

News You Need to Know Today
FDA clears next-gen heart device | Catching up with SCAI's new president | A warning for cath labs | Late-breaking PCI data
Thursday, May 7, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Interventional Cardiology

FDA clears next-gen device for left-heart access

Early data linked the device with short crossing times, reduced fluoro exposure and no device-related adverse events.

READ MORE >
Protaryx Transseptal Puncture Device
Share on Twitter Share on Facebook Share on Linkedin

FDA clears next-gen device for left-heart access

Share on Twitter Share on Facebook Share on Linkedin
Protaryx Transseptal Puncture Device
Early data linked the device with short crossing times, reduced fluoro exposure and no device-related adverse events.
READ MORE >

New SCAI President Dawn Abbott outlines workforce training and inclusion priorities

SCAI President Dawn Abbott, MD, MSCAI, aims to turn attention toward the long-term sustainability of the interventional cardiology field.

READ MORE >
The Society for Cardiovascular Angiography and Interventions (SCAI) is entering a new chapter as Dawn Abbott, MD, MSCAI, who assumeed the presidency this week with a focus on strengthening the future of interventional cardiology through workforce development, expanded training pathways and continued efforts to broaden inclusion in the specialty. #SCAI2026 #SCAI26
Share on Twitter Share on Facebook Share on Linkedin

New SCAI President Dawn Abbott outlines workforce training and inclusion priorities

Share on Twitter Share on Facebook Share on Linkedin
The Society for Cardiovascular Angiography and Interventions (SCAI) is entering a new chapter as Dawn Abbott, MD, MSCAI, who assumeed the presidency this week with a focus on strengthening the future of interventional cardiology through workforce development, expanded training pathways and continued efforts to broaden inclusion in the specialty. #SCAI2026 #SCAI26
SCAI President Dawn Abbott, MD, MSCAI, aims to turn attention toward the long-term sustainability of the interventional cardiology field.
READ MORE >

FDA shares warning about cath lab procedure kits due to risk of patient injury

The syringes included in several convenience kits should not be used due to a safety risk linked to multiple injuries.

READ MORE >
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
Share on Twitter Share on Facebook Share on Linkedin

FDA shares warning about cath lab procedure kits due to risk of patient injury

Share on Twitter Share on Facebook Share on Linkedin
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
The syringes included in several convenience kits should not be used due to a safety risk linked to multiple injuries.
READ MORE >

First bedside procedure of its kind performed by traveling clinicians on premature infant

The 22-week-old patient was successfully treated by a traveling cardiologist—all without being transported to the cath lab.

READ MORE >
Nicklaus Children’s Hospital patent ductus arteriosus (PDA) closure
Share on Twitter Share on Facebook Share on Linkedin

First bedside procedure of its kind performed by traveling clinicians on premature infant

Share on Twitter Share on Facebook Share on Linkedin
Nicklaus Children’s Hospital patent ductus arteriosus (PDA) closure
The 22-week-old patient was successfully treated by a traveling cardiologist—all without being transported to the cath lab.
READ MORE >

Abbott gains FDA clearance, CE mark approval for AI-powered imaging platform

Ultreon 3.0 was built to capture and evaluate OCT images, providing real-time guidance during complex PCI procedures.

READ MORE >
Ultreon 3.0 Abbott
Share on Twitter Share on Facebook Share on Linkedin

Abbott gains FDA clearance, CE mark approval for AI-powered imaging platform

Share on Twitter Share on Facebook Share on Linkedin
Ultreon 3.0 Abbott
Ultreon 3.0 was built to capture and evaluate OCT images, providing real-time guidance during complex PCI procedures.
READ MORE >

Late-breaking PCI data challenge the 'time is muscle' paradigm

Gregg Stone, MD, spoke to Cardiovascular Business about the lessons he and his colleagues learned from the STEMI DTU trial.

READ MORE >
Gregg Stone, MD, FACC, FSCAI, Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai Hospital in New York, presented the results of the long-awaited STEMI Door or Unloading time trial, which takes a different approach to first using a percutaneous heart pump to unload the heart 30 minutes prior to PCI interventions to try and prevent common complications and improve outcomes.
Share on Twitter Share on Facebook Share on Linkedin

Late-breaking PCI data challenge the 'time is muscle' paradigm

Share on Twitter Share on Facebook Share on Linkedin
Gregg Stone, MD, FACC, FSCAI, Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai Hospital in New York, presented the results of the long-awaited STEMI Door or Unloading time trial, which takes a different approach to first using a percutaneous heart pump to unload the heart 30 minutes prior to PCI interventions to try and prevent common complications and improve outcomes.
Gregg Stone, MD, spoke to Cardiovascular Business about the lessons he and his colleagues learned from the STEMI DTU trial.
READ MORE >

CCTA brings clarity, better outcomes to CTO PCI

Researchers reviewed dozens of studies to evaluate the long-term value of using CCTA guidance to perform PCI on patients with complete blockages.

READ MORE >
CCTA characterization of a chronic total occlusion with angiographic correlation during percutaneous coronary intervention.
Share on Twitter Share on Facebook Share on Linkedin

CCTA brings clarity, better outcomes to CTO PCI

Share on Twitter Share on Facebook Share on Linkedin
CCTA characterization of a chronic total occlusion with angiographic correlation during percutaneous coronary intervention.
Researchers reviewed dozens of studies to evaluate the long-term value of using CCTA guidance to perform PCI on patients with complete blockages.
READ MORE >

Fewer stents, positive outcomes: Sirolimus-eluting balloons a safe alternative during PCI

Using a DCB that releases sirolimus over an extended period of time appears to be both safe and effective when treating patients who present with NSTEMI or unstable angina.

READ MORE >
Cordis acquires MedAlliance, known for its drug-eluting balloon technology, in deal that could surpass $1B
Share on Twitter Share on Facebook Share on Linkedin

Fewer stents, positive outcomes: Sirolimus-eluting balloons a safe alternative during PCI

Share on Twitter Share on Facebook Share on Linkedin
Cordis acquires MedAlliance, known for its drug-eluting balloon technology, in deal that could surpass $1B
Using a DCB that releases sirolimus over an extended period of time appears to be both safe and effective when treating patients who present with NSTEMI or unstable angina.
READ MORE >

Sirolimus- and paclitaxel-coated balloons deliver comparable 1-year PCI outcomes

Researchers explored data from more than 8,000 patients treated over a three-year period. 

READ MORE >
Illustration of cardiologists going through the certification process. American College of Cardiology President B. Hadley Wilson, MD, discussed why the ACC and other leading cardiology groups are so eager to create a new, independent medical board. This has been a long-term goal for many years, he said, and now it may become a reality. 
Share on Twitter Share on Facebook Share on Linkedin

Sirolimus- and paclitaxel-coated balloons deliver comparable 1-year PCI outcomes

Share on Twitter Share on Facebook Share on Linkedin
Illustration of cardiologists going through the certification process. American College of Cardiology President B. Hadley Wilson, MD, discussed why the ACC and other leading cardiology groups are so eager to create a new, independent medical board. This has been a long-term goal for many years, he said, and now it may become a reality. 
Researchers explored data from more than 8,000 patients treated over a three-year period. 
READ MORE >

PVL after TTVR linked to much lower survival rate, fewer clinical benefits

TTVR has made a major impact on heart patients all over the world. Just like aortic and mitral valve replacement, however, paravalvular leak is a serious complication that can lead to much worse outcomes.

READ MORE >
Edwards Evoque transcatheter tricuspid valve replacement TTVR.
Share on Twitter Share on Facebook Share on Linkedin

PVL after TTVR linked to much lower survival rate, fewer clinical benefits

Share on Twitter Share on Facebook Share on Linkedin
Edwards Evoque transcatheter tricuspid valve replacement TTVR.
TTVR has made a major impact on heart patients all over the world. Just like aortic and mitral valve replacement, however, paravalvular leak is a serious complication that can lead to much worse outcomes.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Pacemakers recalled again | Johnson & Johnson makes a move | GLP-1 drugs & AFib | Strokes after PFA | New LAAO data
More recalls announced due to high-risk device | AATS helps surgeons manage a major complication | How guidelines impact care
Week in Review: TAVR or SAVR? | Key trends in cardiac CT | Fraud allegations lead to $6.7M settlement | CTO PCI
FDA clears intravascular imaging tech | Key trends in cardiac CT | Heartflow sues rival | Opportunistic screening
Vascular specialist agrees to pay $6.7M | Robotic heart surgery: Worth the cost? | E-cigarette concerns | Heart tech on display
FDA clears next-gen heart device | Catching up with SCAI's new president | A warning for cath labs | Late-breaking PCI data
New data confirm long-term durability of Resilia tissue | CCTA delivers clarity, better outcomes | Cannabis use & heart attacks

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …2
    • Page 3
    • Page 4
    • Page 5
    • Current page 6
    • Page 7
    • Page 8
    • Page 9
    • Page 10 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup